NatWest Group plc - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 134 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NatWest Group plc ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$480,000
-35.9%
31,280
+1.5%
0.01%
+22.2%
Q2 2015$749,000
+3.0%
30,803
-1.5%
0.01%
-10.0%
Q1 2015$727,000
-24.9%
31,280
-18.8%
0.01%
+25.0%
Q4 2014$968,000
-11.2%
38,543
+9.9%
0.01%
-11.1%
Q3 2014$1,090,000
+90.2%
35,058
+58.3%
0.01%
-62.5%
Q2 2014$573,000
+41.5%
22,143
+27.8%
0.02%
+33.3%
Q1 2014$405,000
-9.8%
17,333
-2.1%
0.02%
+63.6%
Q4 2013$449,000
+58.1%
17,709
+27.2%
0.01%
+37.5%
Q3 2013$284,000
+2.9%
13,921
+6.0%
0.01%
+100.0%
Q2 2013$276,00013,1370.00%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 453,392$11,022,0001.89%
GREAT POINT PARTNERS LLC 141,900$3,450,0001.34%
Penn Capital Management Company, LLC 1,247,428$30,325,0001.25%
Ranger Investment Management 982,240$23,878,0001.16%
HealthCor Management, L.P. 912,381$22,180,0001.12%
Piermont Capital Management Inc. 138,380$3,364,0001.02%
JW Asset Management, LLC 111,630$2,714,0000.82%
SECTORAL ASSET MANAGEMENT INC 465,625$11,319,0000.47%
ACUTA CAPITAL PARTNERS, LLC 28,000$681,0000.42%
Tekla Capital Management LLC 409,500$9,955,0000.36%
View complete list of SAGENT PHARMACEUTICALS INC shareholders